Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study - Concepedia

Concepedia

Publication | Closed Access

Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study

34

Citations

32

References

2018

Year

Marianne Bollestad, Nils Grude, Sigrid Solhaug, Niclas Raffelsberger, Nina Handal, Hans-Johnny Schjelderup Nilsen, Monica Regine Romstad, Andreas Emmert, Yngvar Tveten, Arne Søraas,

Journal of Antimicrobial Chemotherapy

Abstract

Pivmecillinam given at 400 mg three times daily gave comparable clinical and bacteriological cure rates in women with community-acquired E. coli UTIs irrespective of ESBL production.

References

	Year	Citations

Page 1